Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹8.1 LAccepted-AOC 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | L1 | Accepted-AOC NOA Issued for 01 Item dated 11-05-2023 | |
| 2 | L1₹41.0 LAccepted-AOC 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | L1 | Accepted-AOC NOA Issued for 02 Items dated 11-05-2023 |
Tender Value
Refer Docs
EMD Value
₹2 L
Closing Date
10 Apr 2023, 3:30 pmClosed
Managing Director
MPPHSCL, Bhopal
Online Tender for the Rate Contract and Supply of Pharmaceuticals to Various Hospitals of Government of Madhya Pradesh for a Period of 18 months (Haemophilia Drug)
2023_PHSCL_259451_1
T-433/MPPHSCL/Haemophilia Drug/RC/2023
Open Tender
Medicines
Item Wise
60 days
MPPHSCL
Please refer Tender documents.
20 documents required · 20 mandatory
₹6,490
Yes
₹2 L
Yes
MPPHSCL, Bhopal
5 Jun 2023
11 Mar 2023
11 Apr 2023
11 Mar 2023
10 Apr 2023
27 Mar 2023
14 Mar 2023
Haemophilia Drug
Extended Half Life (EHL) - recombinant Factor VIII (rFVlII)-Pegylated (Rurioctocog alfa pegol) (500IU)
Extended Half Life (EHL) - recombinant Factor VIII (rFVlII)-Glycopegylated (Turoctocog alfa pegol) (500IU)
Extended Half Life (EHL) - recombinant Factor IX (rFIX)–Glycopegylated (Nonacog beta pegol) (500IU)
Novo Nordisk India Private Limited
Takeda Biopharmaceuticals India Private Limited
stage.html
html • 0.04 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .